Nothing is Better Than Viridian Therapeutics Inc (VRDN) stock at the moment

With 0.88 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.32 million shares. The 52-week range on VRDN shows that it touched its highest point at $27.20 and its lowest point at $11.40 during that stretch. It currently has a 1-year price target of $40.44. Beta for the stock currently stands at 1.05.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VRDN was down-trending over the past week, with a drop of -4.41%, but this was down by -11.34% over a month. Three-month performance dropped to -20.01% while six-month performance rose 3.63%. The stock lost -15.39% in the past year, while it has lost -15.13% so far this year. A look at the trailing 12-month EPS for VRDN yields -4.31 with Next year EPS estimates of -4.16. For the next quarter, that number is -1.04. This implies an EPS growth rate of 23.77% for this year and -2.84% for next year. EPS is expected to grow by 7.47% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 20.35%.

Float and Shares Shorts:

At present, 79.18 million VRDN shares are outstanding with a float of 71.23 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VRDN since 11 analysts follow the stock currently. There are 10 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.86723 being high and -$4.18867 being low. For VRDN, this leads to a yearly average estimate of -$4.04804.